Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Join our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessOur systemic review indicates that EGFR-TKI therapy has improved PFS, and reduced SAEs compared to standard chemotherapy in advanced EGFR-mutated NSCLC.
Hongjoo J. Lee, Gwang Hun Jeong, H. Li, M S Kim, J S Kim, S J Park, Yi Han, Keum Hwa Lee, Andreas Kronbichler, Seok-Il Hong, Ramy Abou Ghayda, Claudio Luchini, Alessia Nottegar, A Koyanagi, Lee Smith, Linu Abraham Jacob, Elena Dragioti, Joaquim Raduà, Sarah Cargnin, Salvatore Terrazzino, Terry Thompson, Dong Keon Yon, S W Lee, J M Yang, Paul Wasuwanich, Jae Il Shin, Gabriele Gamerith (2021). Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.. , 25(20), DOI: https://doi.org/10.26355/eurrev_202110_26993.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2021
Authors
27
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.26355/eurrev_202110_26993
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
